Dr. Hsieh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4650 W Sunset Blvd
# 54
Los Angeles, CA 90027Phone+1 323-361-4829
Summary
- Dr. Emily Hsieh is a pediatric hematologist/oncologist in Los Angeles, CA and is affiliated with Children's Hospital Los Angeles. She specializes in transplantation and cellular therapy with a focus on hematologic malignancies, pediatric hematopoietic stem cell transplantation, adoptive immunotherapy, and chimeric antigen receptor (CAR) T-cell therapy. Her research interests include developing CAR T-cell therapies for hematologic and solid malignancies, as well as evaluating delayed and late effects of CAR T-cell therapy.
Education & Training
- Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2017 - 2020
- Tufts Medical CenterChief Residency, Pediatrics, 2016 - 2017
- Tufts Medical CenterResidency, Pediatrics, 2013 - 2016
- Duke-NUS Graduate Medical School SingaporeClass of 2013, MD
Certifications & Licensure
- MA State Medical License 2016 - 2026
- CA State Medical License 2021 - 2025
- TX State Medical License 2020 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD22 for Relapsed/Refractory Leukemia or Lymphoma Start of enrollment: 2020 Sep 25
- A Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Leukemia Start of enrollment: 2017 Nov 03
- Study of Anti-CD33 Chimeric Antigen Receptor-Expressing T Cells (CD33CART) in Children and Young Adults With Relapsed/Refractory Acute Myeloid Leukemia Start of enrollment: 2020 Jan 08
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsRisk of T-cell malignancy after CAR T-cell therapy in children, adolescents, and young adults.Adam J Lamble, Liora M Schultz, Khanh Nguyen, Emily M Hsieh, Kevin McNerney
Blood Advances. 2024-07-09 - 2 citationsINSPIRED Symposium Part 3: Prevention and Management of Pediatric Chimeric Antigen Receptor T Cell-Associated Emergent Toxicities.Kevin O McNerney, Emily M Hsieh, Haneen Shalabi, Rebecca Epperly, Pamela L Wolters
Transplantation and Cellular Therapy. 2024-01-01 - 3 citationsChimeric Antigen Receptor T Cells as Salvage Therapy for Post-Chimeric Antigen Receptor T Cell Failure.Elizabeth M Holland, Bonnie Yates, Seth M Steinberg, Constance M Yuan, Hao-Wei Wang
Transplantation and Cellular Therapy. 2023-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: